DANIEL BRADBURY - 14 Feb 2025 Form 4 Insider Report for Equillium, Inc. (EQ)

Signature
/s/ Jason A. Keyes, Attorney-in-Fact
Issuer symbol
EQ
Transactions as of
14 Feb 2025
Net transactions value
$0
Form type
4
Filing time
19 Feb 2025, 19:42:33 UTC
Previous filing
07 Feb 2025
Next filing
23 May 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQ Employee Stock Option (right to buy) Award +90,000 90,000 14 Feb 2025 Common Stock 90,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -90,000 -100% 0 14 Feb 2025 Common Stock 90,000 $7.16 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +36,000 36,000 14 Feb 2025 Common Stock 36,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -36,000 -100% 0 14 Feb 2025 Common Stock 36,000 $4.75 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +28,708 28,708 14 Feb 2025 Common Stock 28,708 $0.7850 Direct F2, F3
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -28,708 -100% 0 14 Feb 2025 Common Stock 28,708 $3.53 Direct F2, F3
transaction EQ Employee Stock Option (right to buy) Award +36,000 36,000 14 Feb 2025 Common Stock 36,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -36,000 -100% 0 14 Feb 2025 Common Stock 36,000 $5.03 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +38,000 38,000 14 Feb 2025 Common Stock 38,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -38,000 -100% 0 14 Feb 2025 Common Stock 38,000 $3.59 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Award +50,000 50,000 14 Feb 2025 Common Stock 50,000 $0.7850 Direct F1, F2
transaction EQ Employee Stock Option (right to buy) Disposed to Issuer -50,000 -100% 0 14 Feb 2025 Common Stock 50,000 $1.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
F2 On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.
F3 The shares subject to this option became fully vested on the grant date of May 28, 2020.